27 days to first decision for reviewed manuscripts only
19 days to first decision for all manuscripts
76 days from submission to acceptance
18 days from acceptance to publication
Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
EGFR-tyrosine kinase inhibitors (EGFR-TKIs) have achieved remarkable outcomes in the treatment of patients with EGFR-mutant non-small-cell lung cancer, but acquired resistance is still the main factor restrict...
Citation: Biomarker Research 2019 7:27